| PRU |
Report |
Adjusted EPS |
IN-LINE |
pred ~$3.40 vs. cons $3.42 |
MEDIUM |
| PRU |
Report |
PGIM adjusted operating income (asset mgmt growth engine) |
BEAT |
pred ~$210M vs. cons ~$196M |
LOW |
| PRU |
Report |
Group Insurance benefits ratio (disability soft spot) |
MISS |
pred ~85.5% vs. cons ~84.0% |
MEDIUM |
| PRU |
Guide |
New long-term strategic/financial targets (ROE) — the actual catalyst |
UNKNOWN |
guide new ROE target ~15%+ vs. current ~13% (long-term/multi-year framework) |
MEDIUM |
| PRU |
Guide |
Japan (POJ) FY26 pretax AOI sales-suspension drag |
UNCHANGED |
guide ~$525-575M vs. prior $525-575M (FY26, back-half weighted) |
HIGH |
| PRU |
Guide |
FY26 effective tax rate |
UNCHANGED |
guide ~21-22% vs. prior 21-22% (FY26) |
HIGH |
| PRU |
Guide |
PGIM margin trajectory |
BETTER |
guide ~+200bps to ~21% vs. ~19% run-rate (FY26, toward 25-30% target) |
MEDIUM |
| PRU |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
MEDIUM |
| PRU |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
Stock is +25% off May lows into a Hold-rated Street with PTs ($108-117) below spot ($123), so the bar for the strategy reveal is very high and skewed to sell-the-news. Even on an in-line/small beat, the out-period math cuts estimates: Japan drag is back-half weighted and steps up sequentially (only ~$130M booked in Q1 of the $525-575M FY26 hit), Group disability is leaking, and FY26 EPS is already drifting toward ~$13.80. Unless the strategic framework delivers concrete divestitures + quantified higher-ROE/capital-return targets, downward revisions drive follow-through on the negative day-1 move rather than a bounce. |
LOW |